Amgen (AMGN) is in the recession-proof health care sector and has seen strong sales and earnings even during the recent turmoil on Wall Street.
Amgen is the largest biotechnology company in the world and has products to fight cancer, kidney disease and arthritis. Amgen currently has five "blockbuster" drugs on the market that generate more than $1 billion in annual sales.
This stock consolidated briefly after reporting a slip in sales at the end of April, but the stock has come roaring back nearly 15% since then.
I expect another big leg up for Amgen in anticipation of 2Q earnings, so get into this company right now.
No comments:
Post a Comment